Showing 201 - 210 of 82,024
Persistent link: https://www.econbiz.de/10004584379
Both under- and over-treatment of communicable diseases are public bads. But efforts to decrease one run the risk of increasing the other. Using rich experimental data on household treatment-seeking behavior in Kenya, we study the implications of this tradeoff for subsidizing life-saving...
Persistent link: https://www.econbiz.de/10012460716
Persistent link: https://www.econbiz.de/10014247106
To analyze rubella vaccination strategies we calculated benefits and costs of prevention of rubella. With no vaccination, lifetime expenditures for congenital rubella syndrome in offspring of females are greater than $35 per female (present value). Expenditures for acute rubella are less than...
Persistent link: https://www.econbiz.de/10014129661
Using decision analysis, we estimated the benefits, risks and costs of routine childhood immunization against pertussis. Without an immunization program, we predict that there would be a 71-fold increase in cases and an almost fourfold increase in deaths (2.0 to 7.6) per cohort of one million...
Persistent link: https://www.econbiz.de/10014130031
Direct-to-consumer advertising of pharmaceuticals has led to questions of whether consumers benefit from the additional …
Persistent link: https://www.econbiz.de/10014058701
This paper explores the workings of the patent system in the context of the generation of new pharmaceutical products. First it identifies the relevant characteristics of the patent system and its relation to the market. The paper concedes that, in general, the patent system is probably the best...
Persistent link: https://www.econbiz.de/10014072671
The relationship between costs and health benefits of branded pharmaceuticals remains controversial. This paper … branded pharmaceuticals with both higher costs and increased effectiveness compared to the previous standard of care … the variation in the cost of pharmaceuticals is, therefore, not random but rather associated with variation in QALYs …
Persistent link: https://www.econbiz.de/10013366987